These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 6343132

  • 1. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV, Liutova LV, Karabasova MA, Podorol'skaia LV, Serebriakova TN.
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [Abstract] [Full Text] [Related]

  • 2. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN, Andreenko GV, Tsymanovich SG, Maksimova RA, Sharkova TS.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985 Mar; (2):66-71. PubMed ID: 3157406
    [Abstract] [Full Text] [Related]

  • 3. [State of the fibrinolytic and kinin systems of the blood after physical loading].
    Andreenko GV, Liutova LV, Beniumova OE.
    Fiziol Zh SSSR Im I M Sechenova; 1980 Oct; 66(10):1473-80. PubMed ID: 7192224
    [Abstract] [Full Text] [Related]

  • 4. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV, Serebriakova TN, Shimonaeva EE, Liutova LV, Karabasova MA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983 Oct; (3):51-4. PubMed ID: 6342687
    [Abstract] [Full Text] [Related]

  • 5. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL, Mathew P.
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [Abstract] [Full Text] [Related]

  • 6. [Participation of the kidney in changes in the fibrinolytic system during electroshock].
    Andreenko GV, Podorol'skaia LV.
    Vopr Med Khim; 1984 Nov; 30(4):39-42. PubMed ID: 6542276
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ, Boon GI, Jansen JW, Bouma BN.
    Thromb Haemost; 1993 Apr 01; 69(4):381-6. PubMed ID: 8497851
    [Abstract] [Full Text] [Related]

  • 9. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985 Apr 01; (10):5-19. PubMed ID: 2933082
    [Abstract] [Full Text] [Related]

  • 10. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I, Zietek Z, Kotschy M, Rość D, Tyloch F.
    Pol Tyg Lek; 1996 Feb 01; 51(6-9):91-3. PubMed ID: 8756741
    [Abstract] [Full Text] [Related]

  • 11. Changes in fibrinolytic activity during the course of a single hemodialysis session.
    Kurz H, Lerner RG, Weseley S, Nelson JC.
    Clin Nephrol; 1985 Jul 01; 24(1):1-4. PubMed ID: 4040447
    [Abstract] [Full Text] [Related]

  • 12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 01; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 13. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
    Shimonaeva EE, Liutova LV, Andreenko GV.
    Vopr Med Khim; 1981 Jan 01; 27(6):823-8. PubMed ID: 7199779
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator levels in plasma and urine during exercise and oral contraceptive use.
    Hedlin AM, Milojevic S, Korey A.
    Thromb Haemost; 1978 Jun 30; 39(3):743-50. PubMed ID: 705703
    [Abstract] [Full Text] [Related]

  • 15. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H, Saito M, Jokaji H, Uotani C, Kumabashiri I, Matsuda T.
    Rinsho Byori; 1989 Apr 30; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract] [Full Text] [Related]

  • 16. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion.
    Keber D, Stegnar M, Keber I, Accetto B.
    Thromb Haemost; 1979 Jun 30; 41(4):745-55. PubMed ID: 483247
    [Abstract] [Full Text] [Related]

  • 17. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C, Barton MH, Prasse KW, Moore JN.
    J Am Vet Med Assoc; 1995 Aug 15; 207(4):465-70. PubMed ID: 7591947
    [Abstract] [Full Text] [Related]

  • 18. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P.
    Scand J Clin Lab Invest Suppl; 1982 Aug 15; 162():1-298. PubMed ID: 6221396
    [No Abstract] [Full Text] [Related]

  • 19. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 15; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 20. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 15; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.